 |
Journal articles
Luciferase-expressing Leishmania infantum allows the monitoring of amastigote population size, in vivo, ex vivo and in vitro.
Abstract : Here we engineered transgenic Leishmania infantum that express luciferase, the objectives being to more easily monitor in real time their establishment either in BALB/c mice--the liver and spleen being mainly studied-or in vitro. Whatever stationary phase L. infantum promastigotes population--wild type or engineered to express luciferase-the parasite burden was similar in the liver and the spleen at day 30 post the intravenous inoculation of BALB/c mice. Imaging of L. infantum hosting BALB/C mice provided sensitivity in the range of 20,000 to 40,000 amastigotes/mg tissue, two tissues-liver and spleen-being monitored. Once sampled and processed ex vivo for their luciferin-dependent bioluminescence the threshold sensitivity was shown to range from 1,000 to 6,000 amastigotes/mg tissue. This model further proved to be valuable for in vivo measurement of the efficiency of drugs such as miltefosine and may, therefore, additionally be used to evaluate vaccine-induced protection.
Cited literature [19 references]
https://www.hal.inserm.fr/inserm-00691453
Contributor : Delphine Autard Connect in order to contact the contributor
Submitted on : Thursday, April 26, 2012 - 11:34:06 AM
Last modification on : Tuesday, December 7, 2021 - 4:04:26 PM
Long-term archiving on: : Friday, July 27, 2012 - 2:28:49 AM
Contributor : Delphine Autard Connect in order to contact the contributor
Submitted on : Thursday, April 26, 2012 - 11:34:06 AM
Last modification on : Tuesday, December 7, 2021 - 4:04:26 PM
Long-term archiving on: : Friday, July 27, 2012 - 2:28:49 AM
File
journal.pntd.0001323.pdf
Publisher files allowed on an open archive